Keyphrases
Randomized Controlled Trial
100%
Core Outcome Set
100%
Immune Thrombocytopenic Purpura
100%
Primary ITP
66%
Clinical Practice
33%
Trial Reporting
33%
Data Extraction
16%
Intervention Effectiveness
16%
Clinical Trials
16%
Trial Registries
16%
Adverse Events
16%
Patient Perspective
16%
Search String
16%
International Clinical Trials Registry Platform (ICTRP)
16%
Platelet Count
16%
Inconsistency
16%
Outcome Reporting
16%
Autoimmune
16%
Healthcare
16%
Series Analysis
16%
Therapy Interventions
16%
Immune Thrombocytopenia
16%
Bleeding Symptoms
16%
Platelet Dysfunction
16%
Platelet Response
16%
Medicine and Dentistry
Randomized Controlled Trial
100%
Idiopathic Thrombocytopenic Purpura
100%
Thrombocytopenic Purpura
100%
Clinical Trial
25%
Platelet
25%
Adverse Event
12%
Outcome Assessment
12%
Bleeding
12%
Arsphenamine
12%
Time Series Analysis
12%
Platelet Disorder
12%
Pharmacology, Toxicology and Pharmaceutical Science
Randomized Controlled Trial
100%
Idiopathic Thrombocytopenic Purpura
100%
Thrombocytopenic Purpura
100%
Clinical Trial
25%
Disease
12%
Adverse Event
12%
Bleeding
12%
Arsphenamine
12%
Nursing and Health Professions
Idiopathic Thrombocytopenic Purpura
100%
Thrombocytopenic Purpura
100%
Clinical Practice
25%
Practice Guideline
12%
Disease
12%
Adverse Event
12%
Outcome Assessment
12%
Data Extraction
12%
Bleeding
12%
Time Series Analysis
12%
Arsphenamine
12%
Platelet Count
12%